Requires certain entities to stock opioid antagonists and to store naloxone nasal sprays with or adjacent to automated external defibrillator cabinets.
Summary
Bill S05779 mandates that certain educational and public entities in New York, including school districts and public libraries, must stock opioid antagonists, specifically naloxone nasal sprays, on-site. These opioid antagonists are to be stored in proximity to automated external defibrillators (AEDs) to ensure immediate access during emergencies involving suspected opioid overdoses. The bill requires these entities to maintain adequate quantities and types of opioid antagonists as determined by health authorities and allows trained personnel to administer them in emergencies.
Impact
The bill significantly amends existing education and public health laws in New York by establishing a requirement for specific entities to stock and store opioid antagonists. This change aims to enhance the response to opioid overdoses in public spaces, potentially reducing fatalities associated with such incidents. The inclusion of naloxone with AEDs is particularly noteworthy, as it integrates opioid overdose prevention into existing emergency response protocols.
Sentiment
The sentiment surrounding Bill S05779 appears to be overwhelmingly positive, as evidenced by the voting history. The bill received strong support in committee votes and on the Senate floor, with minimal opposition. This reflects a broad consensus on the importance of addressing the opioid crisis and enhancing public health safety measures.
Contention
While the bill has garnered significant support, there may be concerns regarding the implementation logistics, such as the training of personnel and the financial implications for schools and libraries in stocking these medications. However, no specific opposition points were recorded during the discussions or votes, indicating a general agreement on the need for the legislation.
Same As
Requires certain entities to stock opioid antagonists and to store naloxone nasal sprays with or adjacent to automated external defibrillator cabinets.
Requires certain entities to stock opioid antagonists and to store naloxone nasal sprays with or adjacent to automated external defibrillator cabinets.
Establishes a grant program to assist providers in purchasing opioid antagonists alongside automated external defibrillators; establishes criteria for such grant program.
Requires institutions of higher education to maintain supply of naloxone hydrochloride nasal spray for opioid overdose emergencies and permits emergency administration of naloxone hydrochloride nasal spray by licensed campus medical professionals and resident assistants.
Requires institutions of higher education to maintain supply and develop policy governing use of naloxone hydrochloride nasal spray for opioid overdose emergencies.
Requires institutions of higher education to maintain supply and develop policy governing use of naloxone hydrochloride nasal spray for opioid overdose emergencies.
Payment rates established for certain substance use disorder treatment services, and vendor eligibility recodified for payments from the behavioral health fund.
Cover Outstanding Vulnerable Expansion-eligible Residents Now Act or the COVER Now Act This bill establishes a demonstration program to allow local governments to provide health benefits to the Medicaid expansion population in states that have not expanded Medicaid. Under the program, local governments may provide coverage for individuals who are newly eligible for Medicaid under the Patient Protection and Affordable Care Act (i.e., the Medicaid expansion population) for a maximum of 10 years, or until their respective states expand Medicaid. The bill provides a 100% federal matching rate for the first three years of program participation. The bill prohibits states from taking certain actions against participating localities, such as withholding funding, increasing taxes, or restricting provider participation. States that violate these requirements are subject to certain funding penalties.